Vanda Pharmaceuticals Inc. v. Aurobindo Pharma Limited et al
| Vanda Pharmaceuticals Inc. |
| Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc. and Aurolife Pharma LLC |
| 1:2026cv00562 |
| May 14, 2026 |
| U.S. District Court for the District of Delaware |
| Jennifer L Hall |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 10, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Paul W. Hughes for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
SO ORDERED, re #18 Motion for Pro Hac Vice Appearance of Attorney Paul Hughes and Samoneh Schickel of McDermott Will & Schulte LLP filed by Vanda Pharmaceuticals Inc. Ordered by Judge Jennifer L. Hall on 7/6/2026. (ceg)
|
| Filing 19 Pro Hac Vice Fee - Credit Card Payment received for Paul Hughes and Samoneh Schickel. ( re #18 MOTION for Pro Hac Vice Appearance of Attorney Paul Hughes and Samoneh Schickel of McDermott Will & Schulte LLP )( Payment of $ 100, receipt number ADEDC-5007358).(Silver, Daniel) |
| Filing 18 MOTION for Pro Hac Vice Appearance of Attorney Paul Hughes and Samoneh Schickel of McDermott Will & Schulte LLP - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) |
|
Filing 17
ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent", and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Order can be found on Judge Hall's portion of the District Court's website. Ordered by Judge Jennifer L. Hall on 6/29/2026. (ceg)
|
| Pro Hac Vice Attorney George J. Barry, III for Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., and Aurolife Pharma LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Pro Hac Vice Attorney Michael P. Hogan for Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., and Aurolife Pharma LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
| Pro Hac Vice Attorney Timothy H. Kratz for Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., and Aurolife Pharma LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) |
|
Filing 16
SO ORDERED, re #14 Motion for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry III, and Michael P. Hogan filed by Aurobindo Pharma Limited, Aurolife Pharma LLC, Aurobindo Pharma U.S.A., Inc. Ordered by Judge Jennifer L. Hall on 6/22/2026. (twk)
|
| Filing 15 Pro Hac Vice Fee - Credit Card Payment received for Timothy H. Kratz, George J. Barry III, and Michael P. Hogan. ( re #14 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry III, and Michael P. Hogan )( Payment of $ 150, receipt number ADEDC-4996943).(Myer, R.) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry III, and Michael P. Hogan - filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Aurolife Pharma LLC. (Myer, R.) |
| Filing 13 ANSWER to #1 Complaint, by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Aurolife Pharma LLC.(Myer, R.) |
|
SO ORDERED, re #12 Stipulation and Order to Extend Time for Defendants to Answer, Move or Otherwise Respond to Complaint to June 19, 2026. (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 6/19/2026; Aurobindo Pharma U.S.A., Inc. answer due 6/19/2026; Aurolife Pharma LLC answer due 6/19/2026). Ordered by Judge Jennifer L. Hall on 6/5/2026. (ceg)
|
| Filing 12 STIPULATION TO EXTEND TIME for Defendants, Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., and Aurolife Pharma LLC to Answer, Move or Otherwise Respond to Complaint to June 19, 2026 - filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Aurolife Pharma LLC. (Myer, R.) |
| Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma U.S.A., Inc., Aurolife Pharma LLC filed by Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Aurolife Pharma LLC. (Myer, R.) |
| Filing 10 NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., Aurolife Pharma LLC (Myer, R.) |
| Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (alb) |
| Filing 9 DECLARATION of Service for Aurobindo Pharma Limited by Vanda Pharmaceuticals Inc.. (Attachments: #1 Exhibit A-B)(Silver, Daniel) |
| Filing 8 SUMMONS Returned Executed by Vanda Pharmaceuticals Inc..Aurobindo Pharma U.S.A., Inc. served on 5/15/2026, answer due 6/5/2026. (Joyce, Alexandra) |
| Filing 7 SUMMONS Returned Executed by Vanda Pharmaceuticals Inc..Aurolife Pharma LLC served on 5/15/2026, answer due 6/5/2026. (Joyce, Alexandra) |
| Filing 6 Summons Issued as to Aurobindo Pharma Limited on 5/15/2026; Aurobindo Pharma U.S.A., Inc. on 5/15/2026; Aurolife Pharma LLC on 5/15/2026. (Attachments: #1 Summons Issued, #2 Summons Issued)(mpb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent BlackRock Fund Advisors for Vanda Pharmaceuticals Inc. - filed by Vanda Pharmaceuticals Inc. (mpb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,285,129; 11,850,229; 11,918,556; 10,610,510 ; 10,980,770; 10,071,977 ; 11,566,011; 11,760,740; 12,049,457. (Attachments: #1 Patent/Trademark Report)(mpb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/31/2026. Date of Expiration of Patent: (1/25/2033 (11,285,129; 11,850,229; 10,610,510; 10,980,770), 4/7/2033 (11,918,556), and 2/12/2035 (10,071,977; 11,566,011; 11,760,740; 12,049,457).Thirty Month Stay Deadline: 9/30/2028. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT for Patent Infringement against Aurobindo Pharma Limited, Aurobindo Pharma U.S.A., Inc., and Aurolife Pharma LLC (Filing fee $ 405, receipt number ADEDC-4970186) - filed by Vanda Pharmaceuticals Inc.. (Attachments: #1 Exhibits A-J, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
